SpaceX Hits New Low as Stock Nears IPO Price

SpaceX shares hit a new post-IPO low at $135.40 on Wednesday (down ~40% from post-IPO highs), nearly matching the $135 IPO sale price from June 12. The move is attributed to investor skepticism that the AI trade will prove resilient, despite Wall Street’s generally bullish stance (Oppenheimer reiterated a $250 price target, >80% above the prior close). The stock’s weakness suggests positioning is shifting from “pricing in promise” toward tighter scrutiny of AI-linked spending and partners.

Analysis

This looks less like a fundamental break and more like a de-rating of the entire “AI-adjacent mega-cap private asset” complex. Once a name that had been priced on optionality trades back to its offer level, the marginal buyer is signaling that narrative alone no longer clears the bar; that is a bad read-through for any late-stage private/IPO story that depends on AI branding rather than visible revenue ramps. The second-order effect is tighter IPO pricing for the next wave of infrastructure-adjacent listings and more scrutiny on capex-heavy claims that cannot be translated into bookings or disclosed customer demand.

For INTC and TSLA, the key issue is not the partnership itself but whether it can produce verifiable economics within 1-3 months. If the market is repricing “AI exposure” lower, then strategic tie-ups stop supporting multiples unless they show up in order flow, margins, or guidance; otherwise they become dilution to focus rather than valuation support. That argues for a harder bar on any valuation uplift tied to ecosystem announcements, especially if broader AI semi sentiment (including memory names like SKHYV) cools at the same time.

The contrarian take is that the move may be driven by positioning and supply overhang more than operating deterioration. Index inclusion and post-IPO distribution can create a mechanical air pocket that overshoots fair value, so chasing the short after a 40% drawdown risks getting squeezed on any headline. What would falsify the bearish read is a decisive reclaim of the IPO level on sustained volume plus concrete evidence of monetization, not more bullish commentary.

Key Decisions for Investors

• Short SPCX on any rebound toward $145-$150 over the next 1-2 weeks; use a close above $160 as a stop. Target $120 initially, with downside extending to the low-$110s if the post-IPO bid continues to wash out.
• Put on a relative-value pair: long INTC / short SPCX for 1-3 months. The thesis is that INTC has identifiable execution milestones, while SPCX is still trading on optionality; if the Terafab narrative stays vague, SPCX should underperform by 10-15% versus INTC.
• Buy a 1-3 month SPCX $130/$110 put spread only on a bounce, not into weakness. This limits carry while keeping exposure to a second leg down if the stock fails to reclaim the offer price; risk/reward improves if implied vol stays elevated.
• Avoid initiating new long exposure to AI-themed IPOs until the next deal prices with a meaningful discount to comps. The watch item is whether Csquare has to come at a wider range; that will tell you if this is a one-name air pocket or a broader reopening of valuation discipline.